<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although prothrombotic disorders (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>) are known to increase the risk of graft failure in kidney transplantation only, there are no data on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e> in simultaneous pancreas and kidney transplantation (SPK) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Forty-seven SPK performed between September 2000 and July 2002 underwent routine screening for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Data were retrospectively analyzed in view of complications (relaparotomy, graft <z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:hpo ids='HP_0001733'>pancreatitis</z:hpo>, rejection) and graft function (HbA1c, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>) 3 months posttransplantation </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Twenty-five of forty-seven (53.2%) patients had 30 PTDs </plain></SENT>
<SENT sid="4" pm="."><plain>Homozygous mutations of the MTHFR gene (C677T) were found in six, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor-V Leiden mutation</z:e> (homo- or heterozygous G1691A) in seven, and prothrombin mutation (20210A) in one patient (group 1) </plain></SENT>
<SENT sid="5" pm="."><plain>Group 2 consists of deficiencies of protein C (n=1), of protein S (n=12), of antithrombin (n=1), and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndromes</z:e> (n=2) </plain></SENT>
<SENT sid="6" pm="."><plain>Overall, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e> had no influence on graft <z:mp ids='MP_0005048'>thrombosis</z:mp> (P=0.36) or rejection (P=0.56) </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with homozygous mutations, relaparotomies were more often necessary than in patients without mutations (42.9% vs. 11.8%, P=0.046) </plain></SENT>
<SENT sid="8" pm="."><plain>In group 1, there was a trend toward a higher incidence of graft <z:hpo ids='HP_0001733'>pancreatitis</z:hpo> than in patients without mutations (38.5% vs. 14.7%, P=0.075) </plain></SENT>
<SENT sid="9" pm="."><plain>Three months posttransplantation, HbA1c was 6.0% in patients with and 5.5% in patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e> (P=0.023) </plain></SENT>
<SENT sid="10" pm="."><plain>With regard to serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, no significant differences were observed </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e> are frequent in type-1 diabetics receiving SPK and may have a role in relaparotomies, graft <z:hpo ids='HP_0001733'>pancreatitis</z:hpo>, and pancreas graft function </plain></SENT>
</text></document>